Work

Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

Year: 1999

Type: article

Study design: Clinical Trial

Source: Diabetes Care

DOI: 10.2337/diacare.22.7.1137

Authors: M B Toft-Nielsen, S Madsbad, J J Holst

Institution: Hvidovre Hospital

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1980130009

FWCI: 8.339

Cites:

Cited by: 337

Related to: 9